Press Release: ReposiTrak Reports 16% Increase in Net Income 20% Increase in EPS, for Fourth Quarter of Fiscal 2026

Dow Jones
09/29

Full-Year Net Income Up 8%; Full-Year Diluted EPS of $0.39;

Company Returns $5.3 Million of Capital to Shareholders, Ends Year with $27.3 Million in Cash & No Bank Debt

SALT LAKE CITY--(BUSINESS WIRE)--September 28, 2026-- 

ReposiTrak (NYSE: TRAK), an AI-powered, integrated supply chain platform, today announced financial results for the fourth fiscal quarter and full year ended June 30, 2026.

Fiscal Year Financial Highlights (12 months ended June 30, 2026 vs. 12 months ended June 30, 2025):

   --  Full fiscal year revenue of $23.3 million, up 3% year-over-year. 
 
   --  Operating expense decreased 6% to $15.4 million. 
 
   --  Operating income increased 26% to $7.8 million. 
 
   --  GAAP net income increased 8% to $7.6 million. 
 
   --  Net income to common shareholders was $7.4 million, up 12.0%. 
 
   --  EPS of $0.41 per basic and $0.39 per diluted share. 
 
   --  The Company finished the period with $27.3 million in cash and no bank 
      debt. 
 
   --  The Company generated $8.2 million in cash from operations for fiscal 
      2026. 
 
   --  During the fiscal year, the Company redeemed 175,233 preferred shares 
      for the stated redemption price of $10.70 per share for a total of 
      $1,874,993. 
 
   --  During the fiscal year, the Company repurchased and cancelled 143,904 
      common shares for an average price of $12.50 per share for a total of 
      $1,798,537. 

Fourth Fiscal Quarter Financial Highlights (three months ended June 30, 2026 vs. three months ended June 30, 2025):

   --  Fourth quarter total revenue of $5.6 million, down 3% year-over-year. 
 
 
   --  Operating expense decreased 11% to $3.7 million. 
 
   --  Operating income increased 19% to $1.9 million. 
 
   --  GAAP net income increased 16% to $2.1 million. 
 
   --  Net income to common shareholders was $2.1 million, up 16%. 
 
   --  EPS of $0.11 per basic and diluted share. 
 
   --  On June 18, 2026, the Board declared a quarterly dividend of $0.02 per 
      quarter ($0.08 per share annually) to shareholders of record on June 30, 
      2026. The cash dividends were paid to shareholders of record on or about 
      August 14, 2026. Subsequent dividends will be paid within 45 days of each 
      fiscal quarter end. 

Randall K. Fields, Chairman and Chief Executive Officer of ReposiTrak, commented: "We continue to make progress across each of our businesses, while also developing and scaling our new offering with the SPAR Group. Touchless Merchandising leverages ReposiTrak's technology, identifying supply chain and inventory issues in real time, and SPAR's field organization, which addresses those issues in the store. Together, we believe this creates an innovative and differentiated scan-based trading solution that can deliver meaningful value to both retailers and brands. Customer interest has been strong, and we have already signed initial agreements with suppliers."

"Simultaneously, we continue to expand our leadership position in traceability," continued Mr. Fields. "Food safety remains a significant challenge for the industry. So far in 2026, the industry has faced issues related to Cyclospora, Salmonella Javiana, Listeria and E. coli, resulting in well over 100 recalls, hundreds of hospitalizations and multiple deaths. As we move closer to the government's traceability deadline, we expect these events to further reinforce the need for reliable, end-to-end traceability. ReposiTrak is uniquely positioned as the only provider offering true, touchless traceability from farm to shelf, and we expect demand to accelerate as the deadline approaches."

"Our fiscal 2026 results demonstrate the operating leverage in our business model," concluded Mr. Fields. "Revenue increased 3%, while operating expenses declined 6%, driving a 26% increase in operating income. We also generated $8.2 million in cash from operations and ended the year with more than $27 million in cash and no bank debt. At the same time, we continued to invest in our technology and returned $5.3 million of capital to shareholders through dividends, common stock repurchases and preferred share redemptions. We believe our profitability; cash generation and strong balance sheet give us considerable flexibility to invest in growth while continuing to return capital to shareholders."

Fourth Fiscal Quarter Financial Results (three months ended June 30, 2026, vs. three months ended June 30, 2025):

Revenue was $5.6 million as compared to $5.8 million in the prior-year fourth quarter. Total operating expense was $3.7 million, down 11% compared to $4.2 million last year. SG&A expense was $2.8 million, down 4% from $2.9 million last year. GAAP net income was $2.1 million compared to $1.8 million, an increase of 16%. Net income to common shareholders was $2.1 million, or $0.11 per basic and diluted share, compared to $1.7 million, or $0.09 per basic and diluted share, representing an increase of 19%.

Fiscal Year Financial Results (12 months ended June 30, 2026, vs. 12 months ended June 30, 2025):

Revenue increased 3% to $23.3 million as compared to $22.6 million in the prior-year period. Total operating expense was $15.4 million, down 6% compared to $16.4 million last year. SG&A expense was $11.5 million, up less than 1% from $11.4 million last year. GAAP net income was $7.6 million compared to $7.0 million, an increase of 8%. Net income to common shareholders was $7.4 million, or $0.41 per basic and $0.39 per diluted share, compared to $6.6 million, or $0.36 per basic and $0.35 per diluted share, representing an increase of 12%.

Return of Capital:

During the fiscal year, the Company redeemed 175,233 preferred shares at the stated redemption price of $10.70 per share for a total of approximately $1.9 million. As of June 30, 2026, a total of 160,865 shares of Series B preferred remained issued and outstanding. Since inception, a total of 676,912 preferred shares, including Series B and Series B-1 preferred, at the redemption price of $10.70 per share have been redeemed for a total of approximately $7.2 million. All Series B-1 preferred shares have been redeemed. The remaining amount available for future preferred redemptions is $1.72 million.

During the fiscal year, the Company repurchased 143,904 common shares for a total of $1.8 million at an average of $12.50 per share. The Company has approximately $6.0 million remaining on the $21.0 million total common share buyback authorization.

On June 18, 2026, the Board declared a quarterly dividend of $0.02 per quarter ($0.08 per share annually) to shareholders of record on June 30, 2026. The cash dividends have been paid to shareholders of record on or about August 14, 2026. Subsequent dividends will be paid within 45 days of each fiscal quarter end.

Balance Sheet:

The Company had $27.3 million in cash and cash equivalents at June 30, 2026, compared to $28.6 million at June 30, 2025. As part of a go-to-market collaboration with SPAR Group, ReposiTrak entered into an agreement to provide SPAR with a $4.0 million credit facility and separately acquired approximately $2.4 million of SPAR Group common stock.

Conference Call:

The Company will host a conference call at 4:15 p.m. Eastern today to discuss the Company's results. The conference call will also be webcast and will be available via the investor relations section of the Company's website, www.repositrak.com.

Participant Dial-In Numbers:

Date: Monday, September 28, 2026

Time: 4:15 p.m. ET (1:15 p.m. PT)

Toll-Free: 1-877-407-9716

Toll/International 1-201-493-6779

Conference ID: 13762421

Replay Dial-In Numbers:

Toll Free: 1-844-512-2921

Toll/International: 1-412-317-6671

Conference ID: 13760307

Replay Start: Monday, September 28, 2026, 7:15 p.m. ET

Replay Expiry: Wednesday, October 28, 2026 at 11:59 p.m. ET

About ReposiTrak

ReposiTrak, Inc. (NYSE: TRAK) is an AI-powered, integrated platform that connects retailers, wholesalers, suppliers, and food manufacturers through a suite of applications designed to reduce risk, support regulatory compliance, strengthen operational controls, and protect brand integrity. The ReposiTrak platform serves as a shared system of record across its solution areas, maintaining and synchronizing complex supplier and customer data to enable secure, accurate, and scalable information exchange.

ReposiTrak's solutions are organized into three core product families: traceability, compliance and risk management, and supply chain solutions. Through its scalable, cloud-based platform and U.S.-based team of experts, the Company helps organizations streamline operations, improve data transparency, and meet evolving regulatory requirements across the food supply chain. For more information, visit www.repositrak.com.

Forward-Looking Statement

Any statements contained in this document that are not historical facts are forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Words such as "anticipate," "believe," "estimate," "expect," "forecast," "intend," "may," "plan," "project," "predict," "if", "should" and "will" and similar expressions as they relate to ReposiTrak Inc., ("ReposiTrak") are intended to identify such forward-looking statements. ReposiTrak may from time-to-time update these publicly announced projections, but it is not obligated to do so. Any projections of future results of operations should not be construed in any manner as a guarantee that such results will in fact occur. These projections are subject to change and could differ materially from final reported results. For a discussion of such risks and uncertainties, see "Risk Factors" in ReposiTrak annual report on Form 10-K, its quarterly report on Form 10-Q, and its other reports filed with the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the dates on which they are

made.

 
                          REPOSITRAK, INC. 
                     Consolidated Balance Sheets 
 
                                         June 30,       June 30, 
                                           2026           2025 
                                       ------------  --------------- 
Assets 
Current Assets 
   Cash                                $27,256,008   $ 28,568,805 
   Receivables, net of allowance for 
    doubtful accounts of $249,818 and 
    $242,437 at June 30, 2026 and 
    2025, respectively                   4,613,739      4,133,026 
   Contract asset -- unbilled current 
    portion                                433,783        428,585 
   Prepaid expense and other current 
    assets                                 449,298        555,384 
                                        ----------    ----------- 
Total Current Assets                    32,752,828     33,685,800 
                                        ----------    ----------- 
 
Property and equipment, net                303,896        602,172 
 
Other Assets: 
   Note receivable, net                  2,277,778              - 
   Investment in equity securities, 
    at fair value                        3,462,700              - 
   Deposits and other assets               122,414         22,414 
   Prepaid expense -- less current 
    portion                                  2,762          6,568 
   Goodwill                             20,883,886     20,883,886 
   Deferred income taxes                    51,035              - 
   Capitalized software costs, net               -        128,207 
   Capitalized software development 
    in progress                          1,000,412              - 
                                        ----------    ----------- 
Total Other Assets                      27,800,987     21,041,075 
                                        ----------    ----------- 
 
Total Assets                           $60,857,711   $ 55,329,047 
                                        ==========    =========== 
 
Liabilities and Shareholders' Equity 
Current liabilities 
   Accounts payable                    $   522,404   $    282,146 
   Accrued liabilities                   3,240,318      1,841,839 
   Contract liability -- deferred 
    revenue                              4,509,815      3,175,908 
   Notes payable and financing leases 
    -- current                             232,842        231,225 
                                        ----------    ----------- 
Total current liabilities                8,505,379      5,531,118 
                                        ----------    ----------- 
 
Long-term liabilities 
   Notes payable and financing leases 
    -- less current portion                 61,498        278,748 
                                        ----------    ----------- 
Total liabilities                        8,566,877      5,809,866 
                                        ----------    ----------- 
 
Commitments and contingencies 
 
Stockholders' equity: 
   Preferred Stock; $0.01 par value, 
   30,000,000 shares authorized; 
      Series B Preferred, 700,000 
       shares authorized; 160,865 and 
       336,098 shares issued and 
       outstanding at June 30, 2026 
       and 2025 respectively                 1,609          3,361 
   Common Stock, $0.01 par value, 
    50,000,000 shares authorized; 
    18,189,408 and 18,282,805 issued 
    and outstanding at June 30, 2026 
    and 2025, respectively                 181,896        182,830 
   Additional paid-in capital           59,159,098     62,181,156 
   Accumulated other comprehensive 
    loss                                   (36,708)       (11,256) 
   Accumulated deficit                  (7,015,061)   (12,836,910) 
                                        ----------    ----------- 
Total stockholders' equity              52,290,834     49,519,181 
                                        ----------    ----------- 
Total liabilities and stockholders' 
 equity                                $60,857,711   $ 55,329,047 
                                        ==========    =========== 
 
 
                          REPOSITRAK, INC. 
                Consolidated Statements of Operations 
 
                                            For the Years Ended 
                                                  June 30, 
                                        ---------------------------- 
                                            2026           2025 
                                        ------------  -------------- 
 
Revenue                                 $23,287,319   $22,606,066 
                                         ----------    ---------- 
 
Operating expense: 
   Cost of revenue and product support    3,306,855     3,681,330 
   Sales and marketing                    5,751,151     5,843,272 
   General and administrative             5,738,314     5,602,807 
   Depreciation and amortization            647,637     1,251,514 
                                         ----------    ---------- 
Total operating expense                  15,443,957    16,378,923 
                                         ----------    ---------- 
 
Income from operations                    7,843,362     6,227,143 
 
Other income (expense): 
   Interest income                        1,541,459     1,383,535 
   Interest expense                         (38,483)      (48,671) 
   Gain on lease termination                      -        12,262 
   Realized gain (loss) on short term 
    investments                             (19,052)       97,384 
   Unrealized gain (loss) on short 
    term investments                        192,200       (17,676) 
Income before income taxes                9,519,486     7,653,977 
                                         ----------    ---------- 
 
(Provision) for income taxes             (1,949,999)     (675,850) 
                                         ----------    ---------- 
Net income                                7,569,487     6,978,127 
                                         ----------    ---------- 
 
Dividends on Preferred Stock               (167,804)     (360,306) 
                                         ----------    ---------- 
 
Net income applicable to common 
 shareholders                           $ 7,401,683   $ 6,617,821 
                                         ==========    ========== 
 
Weighted average shares, basic           18,236,000    18,262,000 
                                         ==========    ========== 
Weighted average shares, diluted         18,981,000    19,141,000 
                                         ==========    ========== 
Basic earnings per share                $      0.41   $      0.36 
                                         ==========    ========== 
Diluted earnings per share              $      0.39   $      0.35 
                                         ==========    ========== 
 
Comprehensive income: 
   Net income                           $ 7,569,487   $ 6,978,127 
Other comprehensive loss: 
   Unrealized gain (loss) on 
    available-for-sale securities           (25,452)       16,134 
                                         ----------    ---------- 
Total comprehensive income              $ 7,544,035   $ 6,994,261 
                                         ==========    ========== 
 
 
                          REPOSITRAK, INC. 
                Consolidated Statements of Cash Flows 
                                            For the Years Ended 
                                                  June 30, 
                                        ---------------------------- 
                                            2026           2025 
                                        ------------  -------------- 
Cash flows from operating activities: 
Net income                              $ 7,569,487   $ 6,978,127 
Adjustments to reconcile net income 
to net cash provided by operating 
activities: 
   Depreciation and amortization            647,637     1,251,514 
   Amortization of operating right of 
    use asset                                     -        63,597 
   Amortization of loan discount            (77,778)            - 
   Stock compensation expense               444,510       403,783 
   Gain on termination of operating 
    lease                                         -       (12,262) 
   Unrealized gain (loss) on 
    investments                            (192,200)       17,676 
   Net amortization/accretion               (81,235)            - 
   Realized loss on investments              19,052       (97,384) 
   Common stock received in settlement 
    of accounts receivable               (2,325,000)            - 
   Deferred income tax benefit              (51,035)            - 
   Bad debt expense                         950,000       600,000 
   (Increase) decrease in: 
      Accounts receivables               (1,744,042)   (1,221,596) 
      Operating right of use asset                -       186,709 
      Contract assets and unbilled 
       receivables                           (5,197)            - 
      Long-term receivables, prepaids 
       and other assets                     109,892      (447,479) 
   Increase (decrease) in: 
      Accounts payable                      240,258        17,060 
      Operating lease liability                   -      (250,786) 
      Accrued liabilities                 1,386,550       196,499 
      Deferred revenue                    1,333,907       734,674 
                                         ----------    ---------- 
Net cash provided by operating 
 activities                               8,224,806     8,420,132 
                                         ----------    ---------- 
 
Cash flows from investing activities: 
   Issuance of note receivable           (3,000,000)            - 
   Purchase of property and equipment       (16,594)      (15,965) 
   Investment deposit                      (100,000)            - 
   Capitalization of software 
    development costs in progress        (1,000,412)            - 
   Sale (purchase) of marketable 
    securities                                    -        16,134 
                                         ----------    ---------- 
Net cash (used in) provided by 
 investing activities                    (4,117,006)          169 
                                         ----------    ---------- 
 
Cash flows from financing activities: 
    Common stock buyback/retirement      (1,798,537)     (200,035) 
    Redemption of Series B Preferred     (1,874,993)   (2,999,970) 
    Proceeds from exercise of warrants            -        79,120 
    Proceeds from employee stock plan       104,519       134,346 
    Dividends paid                       (1,635,953)   (1,656,377) 
    Payments on notes payable and 
     capital leases                        (215,633)     (362,442) 
                                         ----------    ---------- 
Net cash used in financing activities    (5,420,597)   (5,005,358) 
                                         ----------    ---------- 
 
Net (decrease) increase in cash and 
 cash equivalents                        (1,312,797)    3,414,943 
 
Cash and cash equivalents at beginning 
 of period                               28,568,805    25,153,862 
                                         ----------    ---------- 
Cash and cash equivalents at end of 
 period                                 $27,256,008   $28,568,805 
                                         ==========    ========== 
 
Supplemental Disclosure of Cash Flow 
Information 
   Cash paid for income taxes           $   734,928   $   435,059 
                                         ==========    ========== 
   Cash paid for interest               $    15,411   $    21,023 
                                         ==========    ========== 
   Cash paid for operating leases       $         -   $    56,244 
                                         ==========    ========== 
 
Supplemental Disclosure of Non-Cash 
Investing and Financing Activities 
   Common Stock to pay accrued 
    liabilities                         $   421,604   $   313,218 
                                         ==========    ========== 
   Dividends accrued on Preferred 
    Stock                               $   167,804   $   360,306 
                                         ==========    ========== 
   Right of use asset                   $         -   $   654,444 
                                         ==========    ========== 
 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260928265480/en/

 
    CONTACT:    Investor Relations Contact: 

John Merrill, CFO

Investor-relations@repositrak.com

Or

FNK IR

Rob Fink

646.809.4048

rob@fnkir.com

 
 

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10